Apheresis Market - Applications (Plasmapheresis, Plateletpheresis,RBC/Erythrocytapheresis,Leukapheresis,Photopheresis), Procedures (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Devices & Disposables - Forecasts To 2017

NEW YORK, Jan. 16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Apheresis Market - Applications (Plasmapheresis, Plateletpheresis,RBC/Erythrocytapheresis,Leukapheresis,Photopheresis), Procedures (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Devices & Disposables - Forecasts To 2017

http://www.reportlinker.com/p01083383/Apheresis-Market---Applications-Plasmapheresis-PlateletpheresisRBC/ErythrocytapheresisLeukapheresisPhotopheresis-Procedures-Therapeutic--Donor-Apheresis/Automated-Blood-Component-Collection-Devices--Disposables---Forecasts-To-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Blood_Supply,_Tissue_Banking_and_Transplantation

Apheresis is a process in which blood of a donor/patient is passed through a medical device, which separates one or more components of blood and returns the remaining with or without extracorporeal treatment or replacement of separated component.

Apheresis involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. Apheresis applications market studied in this report is segmented as plasmapheresis, plateletapheresis, erythrocytapheresis, leukapheresis, and other applications based on the various components collected in apheresis collection and therapeutic apheresis.

The apheresis market is driven by the advantages of apheresis collection over the whole blood collection, huge demand for plasma in plasma fractionation and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market. The global apheresis market was valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017 growing at a CAGR of 11.0% from 2012 to 2017. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future.

North America holds the largest market share of close to 50%, followed by Europe in 2012. In the next five years, emerging countries are estimated to register the highest growth rate, primarily due to increasing investments and huge demand for blood components from countries like China and India with large population.

The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack.

Scope of the Report

The research report categorizes the global apheresis market into procedure, application, technology, product type and end-user. All these markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the apheresis market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

Global Apheresis Market, by Procedure:

Donor Apheresis

Therapeutic Apheresis

Neurologic Disorders

Blood Disorders (TTP, Leukemia, & Others)

Renal Disease

Metabolic Disorders

Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others)

Global Apheresis Market, by Application:

Plasmapheresis

Plateletpheresis

Erythrocytapheresis

Leukoreduction/leukapheresis

Others (photopheresis, lipidpheresis, and Immunoadsoption)

Global Apheresis Market, by Technology:

Centrifugation

Membrane Separation/Filtration

Global Apheresis Markets, By Product type:

Devices

Disposables

Global Apheresis Markets, By End-user:

Blood banks/Blood collection centers

Hospitals & Hospital attached blood banks

Others

Apheresis Markets, By Geography:

North America

Europe

Asia

RoW (Rest of the World)

Each section of the report also provides market trends with respect to drivers, restraints, and opportunities. The report includes 13 company profiles and its competitive landscape section sketches the strategic developments in the market.

TABLE OF CONTENTS

1 INTRODUCTION 16

1.1 KEY TAKE AWAYS 16

1.2 REPORT DESCRIPTION 16

1.3 MARKETS COVERED 18

1.4 STAKEHOLDERS 19

1.5 RESEARCH METHODOLOGY 20

1.5.1 MARKET SIZE 20

1.5.2 MARKET SHARE 20

1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES 20

1.5.4 ASSUMPTIONS 21

2 EXECUTIVE SUMMARY 22

3 MARKET OVERVIEW 25

3.1 INTRODUCTION 26

3.2 MARKET SEGMENTATION 27

3.3 MARKET DYNAMICS 28

3.3.1 DRIVERS 28

3.3.1.1 Blood shortage & blood safety to increase the demand for apheresis blood 28

3.3.1.2 Advantage of apheresis collection over whole blood collection to boost the growth 29

3.3.1.3 Increasing demand for plasma derived products to spur the apheresis market 29

3.3.1.4 Increase in aging population demands growth of apheresis 29

3.3.2 RESTRAINTS 30

3.3.2.1 Lack of awareness & challenges in donor recruitment to restrict the growth of apheresis 30

3.3.2.2 High cost of apheresis procedures to hinder the acceptability 30

3.3.3 OPPORTUNITIES 30

3.3.3.1 Extending reach of apheresis 30

3.3.3.2 Untapped pediatric segment can soon gain importance in apheresis 31

3.4 MARKET SHARE ANALYSIS 32

3.5 END-USER ANALYSIS 33

4 GLOBAL APHERESIS MARKET, BY PROCEDURE 38

4.1 INTRODUCTION 39

4.2 AUTOMATED/APHERESIS BLOOD COLLECTION (DONOR APHERESIS) 40

4.3 THERAPEUTIC APHERESIS 42

4.3.1 NEUROLOGIC DISORDERS 47

4.3.2 BLOOD DISORDERS 49

4.3.3 RENAL DISORDERS 54

4.3.4 METABOLIC DISORDERS 55

4.3.5 OTHER DISORDERS 56

5 GLOBAL APHERESIS MARKET, BY PRODUCT TYPE 57

5.1 INTRODUCTION 58

5.2 DEVICES 59

5.3 DISPOSABLES 65

6 GLOBAL APHERESIS MARKET, BY TECHNOLOGY 67

6.1 INTRODUCTION 68

6.2 CENTRIFUGATION 69

6.2.1 DRIVER & RESTRAINT 72

6.2.1.1 Advantages offered by centrifugation technology over membrane separation 72

6.2.1.2 Centrifugation apheresis process is time-consuming 72

6.3 MEMBRANE SEPARATION 78

7 GLOBAL APHERESIS MARKET, BY APPLICATION 85

7.1 INTRODUCTION 86

7.2 PLASMAPHERESIS 87

7.2.1 DRIVERS 87

7.2.1.1 Huge demand for plasma from biopharmaceutical companies 87

7.2.1.2 New applications and opportunities in developing countries 88

7.3 PLATELETPHERESIS 90

7.4 ERYTHROCYTAPHERESIS 92

7.5 LEUKAPHERESIS 94

7.6 OTHERS 96

8 GEOGRAPHIC ANALYSIS 98

8.1 INTRODUCTION 99

8.2 NORTH AMERICA 100

8.3 EUROPE 105

8.4 ASIA 111

8.5 ROW (REST OF THE WORLD) 116

9 COMPETITIVE LANDSCAPE 121

9.1 INTRODUCTION 121

9.2 MERGERS & ACQUISITIONS 123

9.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 127

9.4 PRODUCTS LAUNCH 133

9.5 EXPANSIONS 135

9.6 OTHER DEVELOPMENTS 136

9.7 APPROVALS 137

10 COMPANY PROFILES 139

10.1 ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF

10.2 B. BRAUN MELSUNGEN AG 143

10.3 CERUS CORPORATION 148

10.4 FENWAL, INC. 152

10.5 FRESENIUS MEDICAL CARE AG & CO. KGAA 156

10.6 HAEMONETICS CORPORATION 162

10.7 HEMACARE CORPORATION 170

10.8 KANEKA CORPORATION 173

10.9 KAWASUMI LABORATORIES, INC. 177

10.10 MEDICA S.P.A 181

10.11 NIKKISO CO., LTD. 184

10.12 TERUMO BCT, INC. 188

10.13 THERAKOS, INC. 192

LIST OF TABLES

TABLE 1 GLOBAL APHERESIS MARKET, BY PROCEDURE, 2010 – 2017 ($MILLION) 22

TABLE 2 PEDIATRIC TRANSFUSIONS IN U.S. BY BLOOD CENTERS AND HOSPITALS IN 2008 (THOUSANDS OF UNITS) 31

TABLE 3 GLOBAL APHERESIS MARKET, BY END-USER, 2010 – 2017 ($MILLION) 34

TABLE 4 BLOOD BANKS & BLOOD COLLECTION CENTERS APHERESIS MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 35

TABLE 5 HOSPITALS & HOSPITAL ATTACHED BLOOD BANKS APHERESIS MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 36

TABLE 6 OTHERS APHERESIS END-USER MARKET, BY GEOGRAPHY,

2010 – 2017 ($MILLION) 37

TABLE 7 GLOBAL APHERESIS (DONOR & THERAPEUTIC APHERESIS) MARKET,

BY PROCEDURE, 2010 – 2017 ($MILLION) 39

TABLE 8 AUTOMATED BLOOD COLLECTION MARKET, BY GEOGRAPHY,

2010 – 2017 ($MILLION) 41

TABLE 9 TYPES OF THERAPEUTIC APHERESIS PROCEDURES 42

TABLE 10 THERAPEUTIC APHERESIS MARKET, BY GEOGRAPHY,

2010 – 2017 ($MILLION) 44

TABLE 11 DISEASE/DISORDER TREATED BY THERAPEUTIC APHERESIS 45

TABLE 12 GLOBAL THERAPEUTIC APHERESIS MARKET, BY DISEASE,

2010 - 2017 ($MILLION) 46

TABLE 13 NEUROLOGIC DISORDERS - THERAPEUTIC APHERESIS MARKET,

BY GEOGRAPHY, 2010 – 2017 ($MILLION) 48

TABLE 14 BLOOD DISORDERS - THERAPEUTIC APHERESIS MARKET,

BY GEOGRAPHY, 2010 - 2017 ($MILLION) 49

TABLE 15 BLOOD DISORDERS THERAPEUTIC APHERESIS MARKET,

BY DISEASES, 2010 – 2017 ($MILLION) 50

TABLE 16 TTP THERAPEUTIC APHERESIS MARKET, BY GEOGRAPHY,

2010 – 2017 ($MILLION) 51

TABLE 17 LEUKEMIA THERAPEUTIC APHERESIS MARKET, BY GEOGRAPHY,

2010 – 2017 ($MILLION) 52

TABLE 18 OTHER BLOOD DISORDER THERAPEUTIC APHERESIS MARKET,

BY GEOGRAPHY, 2010 – 2017 ($MILLION) 53

TABLE 19 RENAL DISORDERS - THERAPEUTIC APHERESIS MARKET,

BY GEOGRAPHY, 2010 – 2017 ($MILLION) 54

TABLE 20 METABOLIC DISORDERS - THERAPEUTIC APHERESIS MARKET,

BY GEOGRAPHY, 2010 – 2017 ($MILLION) 55

TABLE 21 OTHER DISORDERS - THERAPEUTIC APHERESIS MARKET,

BY GEOGRAPHY, 2010 – 2017 ($MILLION) 56

TABLE 22 GLOBAL APHERESIS MARKET, BY PRODUCT TYPE,

2010 – 2017 ($MILLION) 58

TABLE 23 APHERESIS DEVICES MARKET, BY GEOGRAPHY,

2010 – 2017 ($MILLION) 60

TABLE 24 APHERESIS DEVICES MARKET, BY APPLICATIONS,

2010 - 2017 ($MILLION) 61

TABLE 25 APHERESIS DEVICES/SYSTEMS IN THE MARKET 61

TABLE 26 APHERESIS DISPOSABLES MARKET, BY GEOGRAPHY,

2010 – 2017 ($MILLION) 65

TABLE 27 GLOBAL APHERESIS DISPOSABLES MARKET, BY APPLICATION,

2010 – 2017 ($MILLION) 66

TABLE 28 GLOBAL APHERESIS MARKET, BY TECHNOLOGY,

2010 – 2017 ($MILLION) 69

TABLE 29 DENSITY OF BLOOD COMPONENTS (KG/L) 70

TABLE 30 CENTRIFUGATION TECHNOLOGY BASED APHERESIS DEVICES 71

TABLE 31 CENTRIFUGATION-BASED APHERESIS MARKET, BY GEOGRAPHY,

2010 – 2017 ($MILLION) 73

TABLE 32 NORTH AMERICA: CENTRIFUGATION APHERESIS MARKET,

BY COUNTRY, 2010 – 2017 ($MILLION) 74

TABLE 33 EUROPE: CENTRIFUGATION APHERESIS MARKET, BY COUNTRY,

2010 – 2017 ($MILLION) 75

TABLE 34 ASIA: CENTRIFUGATION APHERESIS MARKET, BY COUNTRY,

2010 – 2017 ($MILLION) 76

TABLE 35 ROW: CENTRIFUGATION APHERESIS MARKET, BY COUNTRY,

2010 – 2017 ($MILLION) 77

TABLE 36 SIZE OF BLOOD COMPONENTS 78

TABLE 37 MEMBRANE SEPARATION APHERESIS DEVICES 79

TABLE 38 MEMBRANE SEPARATION-BASED APHERESIS MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION) 80

TABLE 39 NORTH AMERICA: MEMBRANE SEPARATION APHERESIS MARKET,

BY COUNTRY, 2010 – 2017 ($MILLION) 81

TABLE 40 EUROPE: MEMBRANE SEPARATION APHERESIS MARKET,

BY COUNTRY, 2010 – 2017 ($MILLION) 82

TABLE 41 ASIA: MEMBRANE SEPARATION APHERESIS MARKET, BY COUNTRY, 2010 – 2017 ($MILLION) 83

TABLE 42 ROW: MEMBRANE SEPARATION APHERESIS MARKET, BY COUNTRY, 2010 – 2017 ($MILLION) 84

TABLE 43 GLOBAL APHERESIS MARKET, BY APPLICATION,

2010 - 2017 ($MILLION) 86

TABLE 44 PLASMA COLLECTION IN UNITED STATES FROM 2005 TO 2010 (THOUSAND LITERS) 88

TABLE 45 PLASMAPHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION) 89

TABLE 46 GLOBAL PLASMAPHERESIS MARKET, BY PROCEDURE,

2010 - 2017 ($MILLION) 90

TABLE 47 PLATELETPHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION) 91

TABLE 48 GLOBAL PLATELETPHERESIS MARKET, BY PROCEDURE,

2010 - 2017 ($MILLION) 92

TABLE 49 ERYTHROCYTAPHERESIS MARKET, BY GEOGRAPHY,

2010 - 2017 ($MILLION) 93

TABLE 50 GLOBAL ERYTHROCYTAPHERESIS MARKET, BY PROCEDURE,

2010 - 2017 ($MILLION) 94

TABLE 51 LEUKAPHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION) 95

TABLE 52 GLOBAL LEUKAPHERESIS MARKET, BY PROCEDURE,

2010 - 2017 ($MILLION) 96

TABLE 53 OTHER APHERESIS APPLICATION MARKET, BY GEOGRAPHY,

2010 - 2017 ($MILLION) 97

TABLE 54 APHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION) 99

TABLE 55 NORTH AMERICA: APHERESIS MARKET, BY COUNTRY,

2010 - 2017 ($MILLION) 101

TABLE 56 NORTH AMERICA: APHERESIS MARKET, BY PROCEDURE,

2010 - 2017 ($MILLION) 101

TABLE 57 NORTH AMERICA: APHERESIS MARKET, BY APPLICATION,

2010 - 2017 ($MILLION) 102

TABLE 58 NORTH AMERICA: APHERESIS MARKET, BY TECHNOLOGY,

2010 - 2017 ($MILLION) 103

TABLE 59 NORTH AMERICA: APHERESIS MARKET, BY PRODUCT TYPE,

2010 - 2017 ($MILLION) 103

TABLE 60 NORTH AMERICA: APHERESIS MARKET, BY END-USER,

2010 - 2017 ($MILLION) 104

TABLE 61 EUROPE: APHERESIS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION) 106

TABLE 62 EUROPE: APHERESIS MARKET, BY PROCEDURE,

2010 - 2017 ($MILLION) 107

TABLE 63 EUROPE: APHERESIS MARKET, BY APPLICATION,

2010 - 2017 ($MILLION) 108

TABLE 64 EUROPE: APHERESIS MARKET, BY TECHNOLOGY,

2010 - 2017 ($MILLION) 109

TABLE 65 EUROPE: APHERESIS MARKET, BY PRODUCT TYPE,

2010 – 2017 ($MILLION) 109

TABLE 66 EUROPE: APHERESIS MARKET, BY END-USER, 2010 - 2017 ($MILLION) 110

TABLE 67 ASIA: APHERESIS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION) 111

TABLE 68 ASIA: APHERESIS MARKET, BY PROCEDURE, 2010 - 2017 ($MILLION) 112

TABLE 69 ASIA: APHERESIS MARKET, BY APPLICATION, 2010 - 2017 ($MILLION) 113

TABLE 70 ASIA: APHERESIS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION) 114

TABLE 71 ASIA: APHERESIS MARKET, BY PRODUCT TYPE,

2010 - 2017 ($MILLION) 114

TABLE 72 ASIA: APHERESIS MARKET, BY END-USER, 2010 - 2017 ($MILLION) 115

TABLE 73 ROW: APHERESIS MARKET, BY REGION, 2010 - 2017 ($MILLION) 116

TABLE 74 ROW: APHERESIS MARKET, BY PROCEDURE, 2010 - 2017 ($MILLION) 117

TABLE 75 ROW: APHERESIS MARKET, BY APPLICATION, 2010 - 2017 ($MILLION) 118

TABLE 76 ROW: APHERESIS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION) 119

TABLE 77 ROW: APHERESIS MARKET, BY PRODUCT TYPE,

2010 - 2017 ($MILLION) 119

TABLE 78 ROW: APHERESIS MARKET, BY END-USER, 2010 - 2017 ($MILLION) 120

TABLE 79 MERGERS & ACQUISITIONS, 2010 – 2012 123

TABLE 80 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES, 2010 – 2012 127

TABLE 81 PRODUCTS LAUNCH, 2010 – 2012 133

TABLE 82 EXPANSIONS, 2010 –2012 135

TABLE 83 OTHER DEVELOPMENTS, 2010 – 2012 136

TABLE 84 APPROVALS, 2010 – 2012 137

TABLE 85 ASAHI KASEI MEDICAL CO., LTD: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION) 140

TABLE 86 B. BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION) 144

TABLE 87 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENT,

2009 – 2011 ($MILLION) 144

TABLE 88 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY,

2009 – 2011 ($MILLION) 145

TABLE 89 CERUS CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE,

2009 – 2011 ($MILLION) 149

TABLE 90 FRESENIUS MEDICAL CARE AG: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION) 157

TABLE 91 FRESENIUS MEDICAL CARE AG: TOTAL REVENUE, BY SEGMENT,

2009 – 2011 ($MILLION) 158

TABLE 92 FRESENIUS MEDICAL CARE AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION) 158

TABLE 93 HAEMONETICS: TOTAL REVENUE AND R&D EXPENDITURE,

2009 – 2011 ($MILLION) 163

TABLE 94 HAEMONETICS: TOTAL REVENUE, BY SEGMENT,

2009 – 2011 ($MILLION) 164

TABLE 95 HAEMONETICS: DISPOSABLES REVENUE, BY PRODUCT TYPE,

2009 – 2011 ($MILLION) 164

TABLE 96 HAEMONETICS: TOTAL REVENUE, BY GEOGRAPHY,

2009 – 2011 ($MILLION) 165

TABLE 97 KANEKA CORPORATION: TOTAL REVENUE, BY SEGMENT,

2010 – 2012 ($MILLION) 174

TABLE 98 KAWASUMI LABORATORIES, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2008 – 2010 ($MILLION) 178

TABLE 99 KAWASUMI LABORATORIES, INC.: TOTAL REVENUE, BY SEGMENT,

2008 – 2010 ($MILLION) 178

TABLE 100 NIKKISO CO., LTD: TOTAL REVENUE AND R&D EXPENDITURE,

2010 – 2012 ($MILLION) 185

TABLE 101 NIKKISO CO., LTD: TOTAL REVENUE, BY GEOGRAPHY,

2010 – 2012 ($MILLION) 185

LIST OF FIGURES

FIGURE 1 GLOBAL APHERESIS MARKET, BY APPLICATION, 2012 23

FIGURE 2 BLOOD INDUSTRY VALUE CHAIN 26

FIGURE 3 APHERESIS MARKET SEGMENTATION 27

FIGURE 4 APHERESIS MARKET - DRIVERS & RESTRAINTS 28

FIGURE 5 GLOBAL APHERESIS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2011 32

FIGURE 6 KEY GROWTH STRATEGIES, 2010 – 2012 121

To order this report:

Blood_Supply,_Tissue_Banking_and_Transplantation Industry: Apheresis Market - Applications (Plasmapheresis, Plateletpheresis,RBC/Erythrocytapheresis,Leukapheresis,Photopheresis), Procedures (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Devices & Disposables - Forecasts To 2017

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
 

SOURCE Reportlinker